Our top pick for
Moog Inc is an aerospace & defense business based in the US. Moog shares (MOG-A) are listed on the NYSE and all prices are listed in US Dollars. Moog employs 12,623 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$79.12|
|52-week range||$59.26 - $91.65|
|50-day moving average||$77.95|
|200-day moving average||$82.03|
|Wall St. target price||$105.00|
|Dividend yield||$1 (1.24%)|
|Earnings per share (TTM)||$1.38|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-0.98%|
|1 month (2021-09-23)||2.05%|
|3 months (2021-07-23)||-0.42%|
|6 months (2021-04-23)||-6.02%|
|1 year (2020-10-23)||17.84%|
|2 years (2019-10-23)||-5.20%|
|3 years (2018-10-23)||5.11%|
|5 years (2016-10-21)||39.76%|
Valuing Moog stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Moog's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Moog's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 58x. In other words, Moog shares trade at around 58x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Moog's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $319 million.
The EBITDA is a measure of a Moog's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.8 billion|
|Operating margin TTM||8.15%|
|Gross profit TTM||$743.7 million|
|Return on assets TTM||4.35%|
|Return on equity TTM||3.42%|
|Market capitalisation||$2.6 billion|
TTM: trailing 12 months
There are currently 686,039 Moog shares held short by investors – that's known as Moog's "short interest". This figure is 2.7% down from 704,991 last month.
There are a few different ways that this level of interest in shorting Moog shares can be evaluated.
Moog's "short interest ratio" (SIR) is the quantity of Moog shares currently shorted divided by the average quantity of Moog shares traded daily (recently around 118691.86851211). Moog's SIR currently stands at 5.78. In other words for every 100,000 Moog shares traded daily on the market, roughly 5780 shares are currently held short.
However Moog's short interest can also be evaluated against the total number of Moog shares, or, against the total number of tradable Moog shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Moog's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Moog shares in existence, roughly 20 shares are currently held short) or 0.0233% of the tradable shares (for every 100,000 tradable Moog shares, roughly 23 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Moog.
Find out more about how you can short Moog stock.
Dividend payout ratio: 21.69% of net profits
Recently Moog has paid out, on average, around 21.69% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.24% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Moog shareholders could enjoy a 1.24% return on their shares, in the form of dividend payments. In Moog's case, that would currently equate to about $1 per share.
While Moog's payout ratio might seem low, this can signify that Moog is investing more in its future growth.
Moog's most recent dividend payout was on 29 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 August 2021 (the "ex-dividend date").
Moog's shares were split on a 3:2 basis on 3 April 2005. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Moog shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Moog shares which in turn could have impacted Moog's share price.
Over the last 12 months, Moog's shares have ranged in value from as little as $59.2605 up to $91.6535. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Moog's is 1.4577. This would suggest that Moog's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Moog Inc. designs, manufactures, and integrates precision motion and fluid controls and controls systems for original equipment manufacturers and end users in the aerospace, defense, and industrial markets worldwide. The company's Aircrafts Controls segment offers primary and secondary flight controls for military and commercial aircrafts; aftermarket support services; and ground-based navigation aids. Its Space and Defense Controls segment provides controls for satellites, space vehicles, launch vehicles, armored combat vehicles, tactical and strategic missiles, security and surveillance, and other defense applications; and gun aiming, stabilization, and automatic ammunition loading for armored combat vehicles. This segment also offers controls for steering tactical and strategic missiles, and naval surface ships and submarines; and weapons stores management systems for light attack aerial reconnaissance, ground, and sea platforms, as well as slip rings, fiber optic rotary joints, and motors. The company's Industrial Systems segment provides components and systems for applications in injection and blow molding machinery, metal forming presses, and heavy industry customers in steel and aluminum production; supplies electromechanical motion simulation bases for the flight simulation and training applications; and supplies solutions for power generation applications, as well as custom test systems and controls for automotive, structural, and fatigue testing. This segment also offers systems and components for applications in oil and gas exploration and production; components for wind turbine applications; components and systems for diagnostic imaging CT scan medical equipment, sleep apnea equipment, oxygen concentrators, infusion therapy, and enteral clinical nutrition; and hydraulics, slip rings, rotary unions and fiber optic rotary joints, motors, and infusion and enteral pumps.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 22, 2021
Everything we know about the Trump Media and Technology Group IPO, plus information on how to buy in.
Steps to owning and managing Valkyrie Bitcoin Strategy ETF units.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 21, 2021
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.